The biotech’s efforts to bring its vaccines to the country mean navigating political pushback in the U.S. and the risk of ...
In absolute dollar amount, the Cambridge drugmaker had the biggest drop in market cap among any public Massachusetts company ...
With COVID vaccine sales in the doldrums and a respiratory syncytial virus (RSV) vaccine market in “contraction”, Moderna CEO ...
In the mRNA vaccine maker’s 2024 Shareholder Letter, CEO Stéphane Bancel reflected upon the company’s second year ...
Bloomberg on MSN2mon
Moderna’s Bancel Steps Down as Sales Chief, Keeps CEO Role(Bloomberg) -- Stephane Bancel is stepping down as chief commercial officer of Moderna Inc., according to a person familiar ...
The challenge of maintaining the earlier growth achieved by US mRNA medicines specialist Moderna through its COVID vaccine ...
The company is one of a few drugmakers currently developing a vaccine for the illness, which is spreading rapidly through ...
Hosted on MSN1mon
Moderna CEO says he'll work with Trump using 'facts and data'Moderna (MRNA) CEO Stéphane Bancel said that he plans to address any partisan hurdles with the incoming Trump administration’s vaccine and pandemic preparedness policies with “facts and data.” ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback